Patients with meningococcal sepsis generally suffer from disseminated intra
vascular coagulation (DIC), The aim of this study was to address whether th
ese patients have elevated numbers of circulating microparticles that contr
ibute to the development of DIC. Plasma samples from 5 survivors, 2 nonsurv
ivors, and 5 healthy volunteers were analyzed for the presence of micropart
icles by flow cytometry, Ongoing coagulation activation in vivo was quantif
ied by enzyme-linked immunosorbent assay of plasma prothrombin fragment F12, and procoagulant properties of microparticles in vitro were estimated by
thrombin-generation assay. On admission, ail patients had increased number
s of micro particles originating from platelets or granulocytes when compar
ed with controls (P = .004 and P = .008, respectively). Patients had elevat
ed levels of F1+2 (P = .004), and their microparticles supported thrombin g
eneration more strongly in vitro (P = .003) than those of controls. Plasma
from the patient with the most fulminant disease course and severe DIC cont
ained microparticles that expressed both CD14 and tissue factor, and these
microparticles demonstrated extreme thrombin generation in vitro, We conclu
de that patients with meningococcal sepsis have elevated numbers of circula
ting microparticles that are procoagulant. These findings may suggest a nov
el therapeutic approach to combat clinical conditions with excessive coagul
ation activation.
(C) 2000 by The American Society of Hematology.